Science
Dermata Therapeutics Inc (NASDAQ: DRMA) Stock: Can It Change The Game?
In today’s recent session, 0.52 million shares of the Dermata Therapeutics Inc (NASDAQ:DRMA) have been traded, and its beta is 0.52. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.